Introducing Teoxane babyGLOW™: A Predictable, Patient-Friendly Skin Quality Technique

Teoxane babyGLOW™ is a new injection technique designed to enhance skin quality and deliver an immediate glowing effect using TEOSYAL® Redensity 1. Based on a precise 8-point injection approach in the immediate subdermis, the technique ensures homogeneous product diffusion, predictable outcomes, and minimal downtime.

Teoxane babyGLOW™: A Predictable Technique for Skin Quality Enhancement

A new injection technique, Teoxane babyGLOW™, has been developed to enhance skin quality and provide immediate glowing effect using TEOSYAL® Redensity 1. Designed for skin beautification and rejuvenation, the technique delivers fast, homogeneous results with minimal downtime.

The babyGLOW™ technique uses an innovative 8-point injection approach in the immediate subdermis, targeting anatomically defined areas of the face to optimize light reflection and skin smoothness. The product’s high fluidity allows for even diffusion within the immediate subdermal layer, reducing the risk of papule formation commonly seen with superficial skin-quality treatments.

Ther poster notably highlights the following findings: 

  • Clinical imaging using 3D volumetric analysis demonstrated rapid diffusion of the product immediately following injection (after 30 minutes), resulting in a smooth, global enhancement rather than localized volume irregularities.
  • Ultrasound analysis following 1st treatment session confirmed accurate placement in the immediate subdermal layer, good tissue integration, and no unwanted migration. 

These findings show that the Texoane babyGLOW™ technique is supported by a coherent anatomical and biological rationale, offering a predictable, and patient-friendly approach to skin quality enhancement. 

 

1. Caboni S, Sezgin B, Criollo G, Urso S, Baranska-Rybak W, Rosso P, et al. Rationale & Description of a New Treatment Protocol for Skin Beautification and Rejuvenation using a Non-Crosslinked HA [Research e-poster]. IMCAS conference, Paris, France. January 28-31, 2026.